These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 27647169)

  • 1. Contemporary risk estimates of three HbA
    Skrtic S; Cabrera C; Olsson M; Schnecke V; Lind M
    Heart; 2017 Mar; 103(5):353-358. PubMed ID: 27647169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contemporary Risk Estimates of Three HbA1c Variables for Myocardial Infarction in 101,799 Patients Following Diagnosis of Type 2 Diabetes.
    Olsson M; Schnecke V; Cabrera C; Skrtic S; Lind M
    Diabetes Care; 2015 Aug; 38(8):1481-6. PubMed ID: 26015559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delay in treatment intensification increases the risks of cardiovascular events in patients with type 2 diabetes.
    Paul SK; Klein K; Thorsted BL; Wolden ML; Khunti K
    Cardiovasc Diabetol; 2015 Aug; 14():100. PubMed ID: 26249018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between Type 2 Diabetes and All-Cause Hospitalization and Mortality in the UK General Heart Failure Population: Stratification by Diabetic Glycemic Control and Medication Intensification.
    Lawson CA; Jones PW; Teece L; Dunbar SB; Seferovic PM; Khunti K; Mamas M; Kadam UT
    JACC Heart Fail; 2018 Jan; 6(1):18-26. PubMed ID: 29032131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mean HbA
    Forbes A; Murrells T; Mulnier H; Sinclair AJ
    Lancet Diabetes Endocrinol; 2018 Jun; 6(6):476-486. PubMed ID: 29674135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of diabetes duration on the relationship between glycaemic control and risk of death in older adults with type 2 diabetes.
    Ghouse J; Isaksen JL; Skov MW; Lind B; Svendsen JH; Kanters JK; Olesen MS; Holst AG; Nielsen JB
    Diabetes Obes Metab; 2020 Feb; 22(2):231-242. PubMed ID: 31596048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mean HbA1c and mortality in diabetic individuals with heart failure: a population cohort study.
    Elder DH; Singh JS; Levin D; Donnelly LA; Choy AM; George J; Struthers AD; Doney AS; Lang CC
    Eur J Heart Fail; 2016 Jan; 18(1):94-102. PubMed ID: 26663216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Related to Pre-Diabetes Mellitus and Diabetes Mellitus in Heart Failure With Reduced Ejection Fraction: Insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial.
    Kristensen SL; Preiss D; Jhund PS; Squire I; Cardoso JS; Merkely B; Martinez F; Starling RC; Desai AS; Lefkowitz MP; Rizkala AR; Rouleau JL; Shi VC; Solomon SD; Swedberg K; Zile MR; McMurray JJ; Packer M;
    Circ Heart Fail; 2016 Jan; 9(1):. PubMed ID: 26754626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative predictive ability of visit-to-visit HbA1c variability measures for microvascular disease risk in type 2 diabetes.
    Yang CY; Su PF; Hung JY; Ou HT; Kuo S
    Cardiovasc Diabetol; 2020 Jul; 19(1):105. PubMed ID: 32631323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycated Hemoglobin Variability Is Associated With Adverse Outcomes in Patients With Heart Failure Irrespective of Diabetic Status.
    Xu X; Ren QW; Chandramouli C; Ng MY; Tsang CT; Tse YK; Li XL; Liu MY; Wu MZ; Huang JY; Cheang IF; Yang JF; Wang F; Lam CSP; Yiu KH
    J Am Heart Assoc; 2024 May; 13(9):e034109. PubMed ID: 38686852
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemoglobin A1c predicts heart failure hospitalization independent of baseline cardiac function or B-type natriuretic peptide level.
    Kishimoto I; Makino H; Ohata Y; Tamanaha T; Tochiya M; Kada A; Ishihara M; Anzai T; Shimizu W; Yasuda S; Ogawa H
    Diabetes Res Clin Pract; 2014 May; 104(2):257-65. PubMed ID: 24629410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus.
    Gu J; Pan JA; Fan YQ; Zhang HL; Zhang JF; Wang CQ
    Cardiovasc Diabetol; 2018 Jun; 17(1):96. PubMed ID: 29960591
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Long-term Change and Variability in Glycemia With Risk of Incident Heart Failure Among Patients With Type 2 Diabetes: A Secondary Analysis of the ACCORD Trial.
    Segar MW; Patel KV; Vaduganathan M; Caughey MC; Butler J; Fonarow GC; Grodin JL; McGuire DK; Pandey A
    Diabetes Care; 2020 Aug; 43(8):1920-1928. PubMed ID: 32540922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of first stroke in people with type 2 diabetes and its relation to glycaemic control: A nationwide observational study.
    Zabala A; Darsalia V; Holzmann MJ; Franzén S; Svensson AM; Eliasson B; Patrone C; Nyström T; Jonsson M
    Diabetes Obes Metab; 2020 Feb; 22(2):182-190. PubMed ID: 31576643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Good glycaemic control is associated with a better prognosis in breast cancer patients with type 2 diabetes mellitus.
    Chang YL; Sheu WH; Lin SY; Liou WS
    Clin Exp Med; 2018 Aug; 18(3):383-390. PubMed ID: 29572669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between glycaemic control and heart failure in 83,021 patients with type 2 diabetes.
    Lind M; Olsson M; Rosengren A; Svensson AM; Bounias I; Gudbjörnsdottir S
    Diabetologia; 2012 Nov; 55(11):2946-53. PubMed ID: 22895807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between glycated haemoglobin levels and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease: a secondary analysis of the TECOS randomized clinical trial.
    McAlister FA; Zheng Y; Westerhout CM; Buse JB; Standl E; McGuire DK; Van de Werf F; Green JB; Armstrong PW; Holman RR;
    Eur J Heart Fail; 2020 Nov; 22(11):2026-2034. PubMed ID: 32621557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct trajectories of HbA
    Rathmann W; Schwandt A; Hermann JM; Kuss O; Roden M; Laubner K; Best F; Ebner S; Plaumann M; Holl RW;
    Diabet Med; 2019 Nov; 36(11):1468-1477. PubMed ID: 31392761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship Between Glycated Hemoglobin and Stroke Risk: A Systematic Review and Meta-Analysis.
    Mitsios JP; Ekinci EI; Mitsios GP; Churilov L; Thijs V
    J Am Heart Assoc; 2018 May; 7(11):. PubMed ID: 29773578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR).
    Eeg-Olofsson K; Cederholm J; Nilsson PM; Zethelius B; Svensson AM; Gudbjörnsdóttir S; Eliasson B
    J Intern Med; 2010 Nov; 268(5):471-82. PubMed ID: 20804517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.